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ABSTRACT The Gram-negative bacterium Pseudomonas aeruginosa is a common cause of chronic airway infections in individu-
als with the heritable disease cystic fibrosis (CF). After prolonged colonization of the CF lung, P. aeruginosa becomes highly re-
sistant to host clearance and antibiotic treatment; therefore, understanding how this bacterium evolves during chronic infection
is important for identifying beneficial adaptations that could be targeted therapeutically. To identify potential adaptive traits of
P. aeruginosa during chronic infection, we carried out global transcriptomic profiling of chronological clonal isolates obtained
from 3 individuals with CF. Isolates were collected sequentially over periods ranging from 3months to 8 years, representing up
to 39,000 in vivo generations. We identified 24 genes that were commonly regulated by all 3 P. aeruginosa lineages, including
several genes encoding traits previously shown to be important for in vivo growth. Our results reveal that parallel evolution oc-
curs in the CF lung and that at least a proportion of the traits identified are beneficial for P. aeruginosa chronic colonization of
the CF lung.
IMPORTANCE Deadly diseases like AIDS, malaria, and tuberculosis are the result of long-term chronic infections. Pathogens that
cause chronic infections adapt to the host environment, avoiding the immune response and resisting antimicrobial agents. Stud-
ies of pathogen adaptation are therefore important for understanding how the efficacy of current therapeutics may change upon
prolonged infection. One notorious chronic pathogen is Pseudomonas aeruginosa, a bacterium that causes long-term infections
in individuals with the heritable disease cystic fibrosis (CF). We used gene expression profiles to identify 24 genes that com-
monly changed expression over time in 3 P. aeruginosa lineages, indicating that these changes occur in parallel in the lungs of
individuals with CF. Several of these genes have previously been shown to encode traits critical for in vivo-relevant processes,
suggesting that they are likely beneficial adaptations important for chronic colonization of the CF lung.
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Pathogenic microbes and viruses, including those that causeAIDS, tuberculosis, andmalaria, can remain closely associated
with their hosts for decades. While much has been learned about
microbial evolution from long-term in vitro experiments (re-
viewed in reference 1), less is known about pathogen evolution
during chronic infection. Pseudomonas aeruginosa, a ubiquitous
Gram-negative bacterium, is a common cause of chronic illness in
individuals with the heritable disease cystic fibrosis (CF), where it
is the leading cause of morbidity and mortality (2). Upon infec-
tion, individuals withCF are unable to clearP. aeruginosa from the
lungs, where it grows to high cell densities despite competing
microorganisms, a strong host immune response, and antibiotic
treatment (2). Several important features make P. aeruginosa CF
lung infections suitable for studying microbial evolution in vivo.
First, a single clone can colonize the lungs of a patient with CF for
over a decade (3), enabling the study of chronological clonal iso-
lates. In addition,much is known about the CF lung environment,
including carbon source availability, oxygen content, and in vivo
growth rates (4–10).
Previous studies have proposed that P. aeruginosa under-
goes adaptive evolution in the CF lung primarily based on two
observations. (i) There is a high ratio of nonsynonymous to
synonymous mutations that occur over time (11). (ii) Isolates
from chronic infections evolve similar phenotypes, including
the following: formation of small colonies on agar (small col-
ony variants or dwarf strains) (12, 13), overproduction of algi-
nate exopolysaccharide (mucoid strains) (12, 14), quorum-
sensing deficiency (11, 15), motility reduction (16, 17), altered
lipopolysaccharide (18), reduced virulence factor expression
(19, 20), and hypermutation (21). However, it is unclear how
global changes in gene expression mediate these “CF-evolved”
phenotypes.
Transcriptional profiling has been used to identify potential
adaptive traits in two similarly grown Escherichia coli lineages after
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20,000 generations (22). Based on these in vitro experiments, we
hypothesized that transcriptional profiling would identify poten-
tial adaptive expression traits inP. aeruginosa lineages that evolved
in vivo. As detailed analysis of gene expression profiling has not
been performed on sequential P. aeruginosa strains obtained from
multiple individuals with CF, we conducted transcriptomic anal-
yses on 17 chronological clonal isolates collected over 3months to
8 years from 3 CF patients. This reflects approximately 1,200 to
39,000 generations based on a previously estimated P. aeruginosa
doubling time of 100 min in the CF lung (10). Our studies reveal
that parallel changes in gene expression occur during in vivo evo-
lution and that P. aeruginosa uses multiple pathways to establish
chronic infection.
RESULTS
In order to identify gene expression changes that occur during
chronic infection, transcriptional profiling was carried out on
clonal P. aeruginosa isolates collected from 3 patients with CF
(Fig. 1). We anticipated that these analyses would reveal how dif-
ferent molecular processes are coordinated to establish long-term
infection. Clonal isolates were collected between 3 months and
8 years after colonization. Individuals A, B, and C harbored
unique P. aeruginosa clones (data not shown). A strain replace-
ment occurred in individual C between 1983 and 1987, so these
isolates are divided into clonal groups Ca and Cb.
Microarray analyses. The Affymetrix P. aeruginosa GeneChip
was designed from the P. aeruginosa PAO1 genome; therefore, it
may be argued that the changes we observed reflect genetic varia-
tions between isolates rather than gene expression changes. How-
ever, a number of factors do not support this claim. First, the
Affymetrix P. aeruginosa GeneChip is designed to capture genes
using 13 unique 25-mer probes. Therefore, small variations (such
as single-nucleotide polymorphisms) would not be significant
after probe summarization. Second,we considered only genes that
have orthologs in four other P. aeruginosa genomes (seeMaterials
and Methods), so genes that are variable between P. aeruginosa
strains were not included in our analyses. Third, the same
microarray platform has been used successfully to assess the
genomic content of various P. aeruginosa isolates, including envi-
ronmental and CF isolates (23). Based on genomic DNA hybrid-
ization to the Affymetrix P. aeruginosa PAO1 GeneChip, it was
reported that between 96.1% and 97.7% of the P. aeruginosa ge-
nome is conserved, including almost all known virulence factors
FIG 1 Pseudomonas aeruginosa isolates from three individuals with cystic
fibrosis. Note that clonal groups Ca and Cb are isolated from the same indi-
vidual, though they are different clonal groups (confirmed by RAPD assay and
pulsed-field gel electrophoresis [data not shown]). More information is avail-
able in Table S1 in the supplemental material. SCV, small colony variant.
FIG 2 Hierarchical clustering of microarray data. Normalized raw microar-
ray signals of 5,391 genes (mean values for two biological replicates) were used
for clustering. We confirmed that clusters of each clonal group are not depen-
dent on the similarity measurement method by using both a Spearman corre-
lation coefficient (A) and Euclidean distance (B).
Huse et al.
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FIG 3 Microarray heat maps of genes differentially expressed between clonal groups. Differentially expressed genes between clonal group A (A), clonal group
B (B), clonal groupCa (C), and clonal groupCb (D) are shown. Each heatmap shows a subset of differentially expressed genes between clonal groups with signals
of1,000 in at least one strain. Comprehensive lists for these analyses are available in Table S4 in the supplemental material. Red indicates high levels of mRNA,
and blue indicates low levels of mRNA.
P. aeruginosa Parallel Evolution in the CF Lung
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(23). These data suggest that the Affymetrix P. aeruginosa PAO1
GeneChip is able to capture the conserved region of each gene in
most P. aeruginosa strains. Finally, we analyzed our data using the
Affymetrix MAS5 algorithm, which calls the presence or absence
of target cDNAs based on the distribution of perfect match and
mismatch probe signals. If our observations were derived from
mutations that accumulated over time, we would have observed a
high incidence of absence calls in the late strains compared to the
early strains. However, as we report in Table S6 in the supplemen-
tal material, we did not see this trend. These results clearly show
that our observations reflect changes in gene expression rather
than genetic variations.
Clonal isolates cluster by patient. To view the global features
of our transcriptomic data, we first conducted hierarchical clus-
tering of microarray signals obtained from each isolate. We used
two similarity measures, Spearman correlation coefficient and
Euclidean distance, to overcome the bias that can occur with one
similarity measurement. Overall, transcriptomic clustering
(Fig. 2) clearly showed that isolates clustered by clonal group (P
0.001 by analysis of similarity [ANOSIM]) rather than by mor-
phological phenotype (P 0.263 by ANOSIM) or time in the CF
lung (P  0.09 by ANOSIM). Similar results were obtained with
both clustering methods. These data indicate that despite growth
in the lungs for thousands of generations, P. aeruginosa isolates
collected at later time points, at least in regard to gene expression,
resemble the ancestor more than isolates from other individuals.
Multiple solutions for establishing chronic infection exist.
Transcriptional profiling showed that clonal groups are highly
similar, but there are some differences that account for each group
clustering by patient. In order to identify these differences, we
compared clonal groups (including ancestor strains) to each
other. Clonal group A differentially expressed 65 genes, clonal
group B differentially expressed 58 genes, clonal group Ca differ-
entially expressed 119 genes, and clonal group Cb differentially
expressed 99 genes (see Table S4 in the supplemental material). A
majority of these genes were involved in virulence, quorum sens-
ing, alginate production, branched-chain amino acidmetabolism,
and motility (Fig. 3; see Table S4 in the supplemental material).
These data suggest that in regard to gene expression, there are
multiple solutions for establishing chronic infection in the lungs
of patients with CF.
Ancestor strains are early colonizers of the CF lung. To our
knowledge, the ancestors were the first chronically established
strains in each individual. However, these strainsmay have under-
gone adaptation before they were collected. In order to show that
ancestral strains had not already undergone significant adaptation
within the CF lung, we compared ancestor strains A1, B1, and Ca1
to the laboratory reference strain, PA14. PA14 was isolated from
an acute burn wound; it has undergone minimal passage in the
laboratory and maintains many of its original traits, making it a
valuable non-CF reference strain. Ancestor strains A1, B1, and
Ca1 differentially expressed 228, 181, and 265 genes, respectively,
compared to strain PA14 (see Table S5 in the supplemental mate-
rial). In contrast, late isolates showed more than 600 gene expres-
sion changes compared to strain PA14. These results suggest that
the ancestral strains show moderate gene expression changes
compared to strain PA14, but since later isolates showed approx-
imately 3-fold-more differences, the strains are still adapting to
the CF lung. Strain Cb1 exhibited an adaptive phenotype, mu-
coidy, and is likely not the original ancestor of subsequent isolates,
although this strain does display adaptation (see below).
Clonal groups exhibit parallel changes in gene expression.
Wenext examined gene expression changes within each lineage by
comparing the transcriptomes of all isolates in each clonal group
to their ancestor (Fig. 4; see Table S6 in the supplemental mate-
rial).We focused ondifferentially expressed genes thatweremain-
tained throughout infection compared to each ancestor. Isolates
in clonal group A differentially expressed 76 genes; these changes
were maintained over 3 years. Four hundred forty-one changes
were maintained over 8 years in isolates from clonal group B.
Clonal group Ca differentially regulated 37 genes over 3 months,
while clonal group Cb differentially regulated 281 genes over
7 years. These results indicate that 1 to 8% of P. aeruginosa genes
displayed differences in expression after chronic infection within
the CF lung.
Although the environment of theCF lung likely differs between
individuals, we hypothesized that due to strong selective pressures
in all patients (immune response, treatment, and consistent nu-
tritional environment), P. aeruginosa isolates from different pa-
tients would display common changes in gene expression. To test
this hypothesis, we compared the above within-group analyses
and identified a set of genes that were commonly differentially
expressed within all 3 lineages (Table 1). Clonal group Ca evolved
FIG 4 Microarray heat map of differentially expressed genes within clonal
groups. All strains in each clonal group were compared to their ancestor (ini-
tial strain) and evaluated for significant changes in gene expression (2-fold
change and FDR of 0.05). The numbers used to generate this heat map are
the mean fold changes (log2) in mRNA levels compared to the mRNA level of
the ancestor strain of each clonal group. Red indicates an increase in the
mRNA level, and blue indicates a decrease in the mRNA level. All genes de-
tected in this analysis are reported separately in Table S6 in the supplemental
material.
Huse et al.
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over a short time period, 3 months; therefore, it was excluded
from the analysis. Twenty-four genes commonly changed over
time in clonal groups A, B, and Cb. Importantly, these genes
changed in the same direction across all 3 lineages. Nine genes
were downregulated, and 15 were upregulated. Four of the down-
regulated genes encoded proteins of unknown function, while the
remaining were involved in type 4 fimbrial biogenesis. Ten genes
encoding proteins of unknown function were upregulated. The
other upregulated genes encode two outer membrane proteins
(PA1048, OsmE), PA4880 (probable bacterioferritin), phaF
(polyhydroxyalkanoate synthesis protein PhaF), and PA1562 (ac-
onitase). Additionally, 86 genes were commonly regulated in at
least 2 lineages (Fig. 5; see Table S6 in the supplemental material).
Many of these genes were involved in flagellar biosynthesis, fim-
brial (pilus) biosynthesis, and polyamine transport. The appear-
ance of similar alterations in gene expression patterns, particularly
changes in the same direction, suggests that P. aeruginosa under-
goes parallel evolution in the CF lung.
DISCUSSION
Our goal was to identify adaptive expression traits of P. aeruginosa
during chronic CF lung infection. Our study is limited by the
absence of genetic data because we cannot correlate specific mu-
tations with changes in gene expression, and pleiotropic effects
cannot be ruled out. However, since genetic mutations can affect
gene expression, our study is important for understanding the
global evolution of P. aeruginosa during chronic infection. Our
transcriptional analysis is the most comprehensive study of this
type thus far. While D’Argenio et al. (24) and Hoboth et al. (25)
compared transcriptional profiles of early and late isolates, these
studies were limited by the number of samples or patients. In
contrast, we characterized chronological, clonal isolates collected
from multiple CF patients.
We identified 24 genes that showed similar changes in gene
expression across 3 separate P. aeruginosa lineages. This is striking
because our statistical analyses show that overlap between groups
is highly significant (P value1010) (Fig. 5), so the probability of
identifying 24 genes by random chance is very low. Since patients
withCF can carry diverse populations ofP. aeruginosa at any given
time, one obvious limitation to this study is sampling. However,
all 3 late isolates recovered on the same date from patient B (B3.1,
B3.2, and B3.3) showed 23 of 24 common gene expression
changes, which strongly supports parallel evolution. Parallel evo-
lution occurs when two closely related organisms independently
develop the same adaptive traits due to the nature of their envi-
ronments (reviewed in reference 26). Parallelism is indicative of
adaptive evolution, which has been proposed to occur in the CF
lung (11). Our data are similar to those of Cooper et al. (22), who
demonstrated that 2 independently evolving E. coli populations
growing under similar laboratory conditions displayed the same
59 changes in gene expression after 20,000 generations. Later, Bar-
rick et al. (27) showed that most of the 45 mutations occurring in
this long-term evolution experiment were beneficial.
FIG 5 Common gene expression changes among three clonal groups. Venn
diagram showing common changes in gene expression between three clonal
groups (groups A, B, and Cb). The 24 genes commonly regulated in the three
clonal groups are listed in Table 1. Genes that are positively regulated over time
() and genes that are negatively regulated over time (-) are indicated (for
instance, in the red circle at the top of the figure, of the 16 genes, 4 genes were
positively regulated over time and 12 genes were negatively regulated over
time.) The P value for the two clonal groups was calculated using a hypergeo-
metric test and indicates that the probability of identifying the overlapping
genes by randomchance is very low. The full list of genes is available inTable S6
in the supplemental material.
TABLE 1 Genes exhibiting parallel expression changes in three clonal
groupsa
Geneb Annotationb
Change in
expressionc
PA0045 Hypothetical protein Decrease
PA0046 Hypothetical protein Decrease
PA0047 Hypothetical protein Decrease
PA0411 (pilJ) Type 4 fimbrial biogenesis protein Decrease
PA5041 (pilP) Type 4 fimbrial biogenesis protein Decrease
PA5042 (pilO) Type 4 fimbrial biogenesis protein Decrease
PA5043 (pilN) Type 4 fimbrial biogenesis protein Decrease
PA5044 (pilM) Type 4 fimbrial biogenesis protein Decrease
PA5139 Hypothetical protein Decrease
PA1048 Probable outer membrane protein precursor Increase
PA1106 Hypothetical protein Increase
PA1323 Hypothetical protein Increase
PA1324 Hypothetical protein Increase
PA1471 Hypothetical protein Increase
PA1562 (acnA) Aconitase Increase
PA1592 Hypothetical protein Increase
PA2485 Hypothetical protein Increase
PA2779 Hypothetical protein Increase
PA3040 Conserved hypothetical protein Increase
PA3691 Hypothetical protein Increase
PA4876 (osmE) Osmotically inducible lipoprotein Increase
PA4880 Probable bacterioferritin Increase
PA5060 (phaF) Polyhydroxyalkanoate synthesis protein Increase
PA5178 Conserved hypothetical protein Increase
a Only genes that have a2-fold change in mRNA levels compared to the mRNA level
of each ancestor strain (FDR of0.05), changed in clonal groups A, B, and Cb, and
maintained changes over time are listed. The raw data are available in Table S6 in the
supplemental material.
b Annotation data were downloaded from the Pseudomonas Genome Database on 23
November 2009.
c mRNA levels of the late strains were compared to those of the ancestor strain in each
clonal group. “Increase” indicates that mRNA levels were higher in the late strains than
in the ancestor strain, and “decrease” indicates that mRNA levels were lower in the late
strains than in the ancestor strain.
P. aeruginosa Parallel Evolution in the CF Lung
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On the basis of these data, we hypothesize that some of the 24
commonly regulated genes encode adaptive traits (Table 1). There
are several lines of evidence to support this claim. First, strong
parallelism is a good indicator of adaptive evolution. Second, 5
fimbrial (pilus) biosynthetic genes (pilJ, pilP, pilO, pilN, and pilM)
were downregulated over time in all 3 lineages (Table 1). It is well
documented that the loss of pili protects P. aeruginosa from
phagocytosis in vivo by neutrophils, thus allowing P. aeruginosa to
escape a primary immune component in the lungs of patients with
CF (16, 28–30). Third, 4 genes important for P. aeruginosa biofilm
formation in vitro (PA5139, PA1592, PA2779, and PA4876) and 3
genes upregulated during biofilm growth in vitro (PA1471,
PA4876, and PA1324)were differentially regulated over time in all
3 lineages (31–33). Resistance to antibiotics and to host clearance
is partly attributed to P. aeruginosa biofilm growth in the CF lung
(34–36), suggesting that adaptation to the biofilm lifestyle via dif-
ferential expression of these genes is important for maintaining
long-term infections. Finally, of the 24 genes, 3 (PA4876, PA1323,
and PA1324) were upregulated in an important P. aeruginosa CF
isolate, the Liverpool epidemic strain (LES), compared to labora-
tory strain PAO1 (37). LES is a particularly virulent P. aeruginosa
CF strain; thus, expression of these traits may represent an impor-
tant adaptation to the lung environment.
Our results indicate that parallel evolution occurs in the lungs
of individuals with CF; however, our data also show that specific,
within-lineage changes also occur. The contribution of parallel
changes versus within-lineage changes is unclear. The number of
traits identified as evolving in parallel (24) is smaller than the
number of changes in gene expression within lineages (up to 441)
andmay represent only a core set of changes (Fig. 5). For example,
distinct virulence traits appear to be utilized by different clonal
groups to establish and maintain infection, supporting previous
hypotheses that P. aeruginosa employs unique evolutionary path-
ways to establish chronic infection (38) and that genes required
for pathogenicity in one strain may not be required or predictive
for others (38–40). Thus, we propose that natural selection may
not be acting on individual virulence traits, but instead on some or
all of the 24 genes identified in our study.
In microbes, parallel gene expression changes have been ob-
served only in long-term in vitro evolution experiments. Our
study shows parallel changes in gene expression of strains grown
in vivo for up to 39,000 generations. It should be noted that we
measured gene expression in vitro. While it is well documented
that the medium used to grow bacteria in this study (synthetic
cystic fibrosis sputum medium [SCFM]) closely mimics the nu-
tritional environment of the CF lung (7), the number of traits
undergoing parallel evolution may be underestimated, or some
may be expressed only under our culture conditions. It would be
ideal to sample P. aeruginosa RNA directly from sputum samples
from patients with CF, but the extraction process is challenging
andwould likely reflect species heterogeneity. Finally, 19 genes (of
24) identified in this study represent traits that have not been
previously identified as adaptive in the CF lung and are therefore
temporalmarkers for P. aeruginosa chronic colonization.Many of
these genes encode proteins of unknown function, suggesting that
future studies aimed at understanding the roles of these genes
could provide unique insight into selective pressures in the CF
lung.
MATERIALS AND METHODS
Isolate collection and genetic analyses. Clonal isolates of P. aeruginosa
were collected and clonally purified from three patients with CF at the
British Columbia’s Children’s Hospital, Shaughnessy Hospital, or St.
Paul’s Hospital (all three hospitals are located in Vancouver, British Co-
lumbia, Canada) as previously described (16). Briefly, P. aeruginosa was
isolated from sputum or throat samples and plated on Columbia agar
supplemented with 5% sheep blood, MacConkey agar, or chocolate agar.
On the basis of morphology, isolates were characterized as classic (C),
dwarf (D), or mucoid (M) (12). Isolates A1, B1, and Ca2 were collected
from respiratory sites, and the remaining isolates were collected from the
throat or sputum (Fig. 1; see Table S1 in the supplemental material). The
isolates were subcultured on Columbia blood agar, resuspended in 2 ml
Mueller-Hinton broth with 8% dimethyl sulfoxide (DMSO), and stored
at75°C. To confirm that the isolates wereP. aeruginosa, theywere plated
on a selective medium, FC agar (41). Genomic DNA extraction and ge-
netic typing were carried out as previously described (3). P. aeruginosa
isolates were typed by randomly amplified polymorphic DNA (RAPD)
typing using primer 272 (3). All isolates from each individual are clonal
except for patient C; a strain replacement occurred in patient C between
1983 and 1987 (Fig. 1; see Table S1 in the supplemental material). For
clarity, clonal isolates from individuals A, B, and C will be referred to as
clonal groups A, B, Ca, and Cb. Isolates collected from patient C are split
into 2 clonal groups, Ca andCb, due to the aforementioned strain replace-
ment. Chronological isolates from each clonal set are designated by the
patient letter (A, B, Ca, and Cb) along with the temporal order of isola-
tion. For example, A1 was the first isolate collected from individual A, A2
was the second isolate, and A3.1 and A3.2 were isolated on the same date
but displayed different morphologies (Fig. 1; see Table S1 in the supple-
mental material).
P. aeruginosa annotation. All analyses were based on the P. aerugi-
nosa PAO1 annotation (downloaded from the Pseudomonas Genome
Database on 23 November 2009). To exclude PAO1 strain-specific genes,
we defined a conserved gene set using 4P. aeruginosa genomesmaintained
at PseudoCAP (PAO1, PA14, PA7, and LESB58) based on the reciprocal
best-hit BLAST method. We identified 5,465 PAO1 genes (out of 5,569
PAO1 genes; 4,699 genes were conserved among all 4 strains) that have at
least one ortholog in the other 3 strains; these genes were considered for
further analysis (see Table S2 in the supplemental material). To assign
microarray probe sets to these genes, we downloaded probe sequences
from the Affymetrix website (Affymetrix, Santa Clara, CA) and mapped
them to the P. aeruginosa PAO1 genome (GenBank accession no.
NC002516.2) by using Exonerate (version 2.20) (42). After discarding
probes that were not uniquely mapped on the genome, we mapped them
again to P. aeruginosa PAO1 cDNA sequences. If less than 12 probes or
more than 14 probes in a probe set were mapped to a gene, it was dis-
carded, since each genewas represented by 13 unique probes. Thus, a total
of 5,391 coding genes were considered in microarray data analysis (see
Table S3 in the supplemental material).
Expression profiling with Affymetrixmicroarrays.Microarray anal-
yses were performed in duplicate on clonal isolates from 3 different indi-
viduals with CF. These analyses included the following strains: A1, A2,
A3.1, A3.2, A4 (A strains from individual A), B1, B2.1, B2.2, B2.3, B3.1,
B3.2, B3.3 (B strains from individual B), Ca1, Ca2, Cb1, Cb2, Cb3 (Ca and
Cb strains from individual C), UCBPP-PA14 (PA14), and PAO1. Clinical
isolates and the reference strains PA14 and PAO1 (6) were routinely
grown on Difco blood agar base (BD Sciences) supplemented with 5%
sheep blood (Remel) or brain heart infusion agar (Fisher). All Affymetrix
GeneChip experiments were performed in synthetic cystic fibrosis spu-
tum medium (SCFM), which mimics the nutritional environment of the
CF lung (7). Bacterial growth in liquid medium (25 ml in a 250-ml flask)
was monitored by measuring the optical density at 600 nm (OD600) dur-
ing growth at 37°C with shaking at 250 rpm.
Global gene expression profiling was carried out as previously de-
scribed (6, 43) with minor modifications. P. aeruginosa isolates were
Huse et al.
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grown in SCFM, and the cells were harvested during exponential phase
(OD600 of 0.4 to 0.5). Cultures were mixed 1:1 with RNAlater (Ambion),
an RNA-stabilizing agent. RNA was isolated using the RNeasy minikit
(Qiagen), and cDNA was prepared for Affymetrix GeneChip microarray
analysis as previously described (6, 43). PCR amplification of the
P. aeruginosa rplU gene (44, 45) was used to detect DNA contamination
using the primers rplU-For (named For for forward primer) (5=-
CGCAGTGATTGTTACCGGTG-3=) and rplU-Rev (named Rev for re-
verse primer) (5=-AGGCCTGAATGCCGGTGATC-3=). To assess RNA
integrity, the samples were subjected to agarose gel electrophoresis. Af-
fymetrix GeneChips were washed, stained, and scanned using an Af-
fymetrix fluidics station at the University of Iowa DNA core facility.
Microarray analyses. We preprocessed microarray .CEL files by the
RMA (robust multiarray analysis) method by using the affy package (ver-
sion 1.18.2) (46) in R (version 2.8.1) with default options (correctionwith
perfect match probes only, quantile normalization, and expression mea-
sure by median polish). Hierarchical clustering analysis was performed
with these signals after summarizing two signals frombiological replicates
by their mean and tested by both Euclidean distance and Spearman cor-
relation coefficient as similarity measures.
Gene expression differences were evaluated by a linear model, imple-
mented on the limma package in R (version 2.16.5) (47). If the maximum
signal of the probe set among all isolates was less than 100, it was not
considered in the analysis. We considered genes to be significantly differ-
entially expressed if they changed 2-fold and the false discovery rate
(FDR) was less than 0.05. Differentially expressed genes between clonal
groups (see Table S4 in the supplemental material) were identified by the
following 2 steps. (i) We compared the expression levels of all isolates in
the same clonal group to those in another clonal group. (ii) We identified
differentially expressed genes between two groups based on an FDR of
0.05 and a 2.0-fold change. Differentially expressed genes over time
within clonal groups (see Table S6 in the supplemental material) were
identified by the following five steps or criteria. (i)We compared the gene
expression levels of all isolates from each clonal group to the ancestor. (ii)
We identified differentially expressed genes based on an FDR of 0.05
and a 2.0-fold change. (iii) We discarded genes that changed in the
direction opposite the direction of the ancestor (i.e., upregulated in the
intermediate isolate and downregulated in the late isolate). (iv) If the level
of gene expression was significantly different in any isolate within the
same group, it was selected. (v) If a gene was expressed differently in both
the intermediate and late isolates, it was selected. ANOSIM test was con-
ducted by using the vegan (http://vegan.r-forge.r-project.org/) package
in R (48).
Microarray data accession number. All microarray data are avail-
able at the NCBI GEO database (accession no. GSE21966). Supple-
mental material is also available on the World Wide Web at
http://www.marcottelab.org/index.php/PSEAE_CF.2010.
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